Source:http://linkedlifedata.com/resource/pubmed/id/19188044
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2009-3-23
|
pubmed:abstractText |
Most type 1 diabetes mellitus is caused by autoimmune pancreatic beta-cell destruction. Several antigens such as insulin, glutamic acid decarboxylase (GAD) and islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP) are considered to take part in the autoimmune destructive process. Because the role of GAD in the disease process of type 1 diabetes is still controversial, we investigated the disease phenotype upon in vivo induction of whole GAD65 reactivity using a GAD65 homo knockout NOD splenocytes to NOD-scid transfer system. Splenocytes from 8 to 10-week-old female GAD65 homo knockout (=KOT splenocytes) or age-matched wild type (=WTT splenocytes) NOD mice were transferred into female NOD-scid recipients. As compared to recipients of WTT splenocytes, the onset of diabetes in recipients of KOT splenocytes was significantly delayed (p<0.001). Moreover, TGF-beta expression was enhanced in the pancreas from recipients of KOT splenocytes. Splenocytes from recipients of KOT splenocytes produced IL-10 (/IFN-gamma) upon GAD65 stimulation, whereas those from recipients of WTT splenocytes did not. Based upon these results, we propose that anti-whole GAD65-reactive T cells have the ability to regulate the development of type 1 diabetes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1095-9157
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
32
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
104-9
|
pubmed:meshHeading |
pubmed-meshheading:19188044-Animals,
pubmed-meshheading:19188044-Antibodies,
pubmed-meshheading:19188044-Cytokines,
pubmed-meshheading:19188044-Diabetes Mellitus, Type 1,
pubmed-meshheading:19188044-Female,
pubmed-meshheading:19188044-Glutamate Decarboxylase,
pubmed-meshheading:19188044-Lymphocytes,
pubmed-meshheading:19188044-Male,
pubmed-meshheading:19188044-Mice,
pubmed-meshheading:19188044-Mice, Inbred NOD,
pubmed-meshheading:19188044-Mice, Knockout,
pubmed-meshheading:19188044-Pancreas,
pubmed-meshheading:19188044-Spleen
|
pubmed:year |
2009
|
pubmed:articleTitle |
Induction of anti-whole GAD65 reactivity in vivo results in disease suppression in type 1 diabetes.
|
pubmed:affiliation |
Department of Internal Medicine, Keio University School of Medicine, Shimanomachi Shinjuku-ku, Tokyo, Japan.
|
pubmed:publicationType |
Journal Article
|